CVS Health (CVS) shares plunged Tuesday on mixed third quarter results despite posting a 24% increase in profits to $1.64 a share, topping analyst estimates by $0.07 a share. However, while revenue jumped 16% in the period to $44.62 billion, that total missed analysts' estimates. For the current quarter, the drugstore chain expects to earn between $1.64 and $1.70 a share vs. Wall Street's expectations of earnings of $1.79 a share.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.